Chinese Vice Premier Liu Guozhong inspected the Brain-Computer Interface Research Institute at Nanjing University on the second day of a Jiangsu Province inspection tour, per Xinhua reporting on 23 June 2026 and a same-day Nanjing University release. The inspection was part of a 22-23 June 2026 tour focused on the science, technology, and health sectors in the province. During the visit, Liu Guozhong described brain-computer interfaces as “a major frontier technology and a key area of international industrial competition,” per the Xinhua English wire. The Nanjing University release records the same statement with slightly different phrasing, framing BCI as “a major cutting-edge technology on the international stage and a strategic high ground in industrial competition.” The verbatim language across the two state-issued accounts is consistent.

Who Liu Guozhong is and what his portfolio covers

Liu Guozhong has been a member of the Politburo of the Chinese Communist Party since the 20th Party Congress in October 2022 and has served as the fourth-ranked Vice Premier of the State Council under Premier Li Qiang since March 2023. Within the State Council’s four-vice-premier structure, Liu’s portfolio covers agriculture and rural affairs, water resources, poverty alleviation, and meteorology, with the Xinhua wire framing his inspection as supporting the broader Healthy China goal. Industry and information technology policy in the conventional sense sits with Vice Premier Zhang Guoqing, not with Liu. Science and technology coordination sits with First Vice Premier Ding Xuexiang.

The portfolio match matters for reading the political signal. A vice premier statement on BCI from the Healthy China brief frames brain-computer interfaces as a public-health and biomedicine priority. This is structurally different from a vice premier statement on BCI as an export-industrial-policy priority, which would have come from the industrial-policy or finance brief. The Xinhua wire confirms this framing: Liu’s speech wrapped the BCI remarks inside a broader call to build biomedicine into an “emerging pillar industry” and to foster BCI as a “future industry” in the service of a Healthy China.

What he actually said

Per Xinhua and Nanjing University, Liu Guozhong urged the Brain-Computer Interface Research Institute to deepen interdisciplinary integration across neuroscience, biomedical engineering, materials science, and information technology. He called for strengthened basic research on brain mechanisms, accelerated breakthroughs in key and core BCI technologies, and enhanced original innovation. The Nanjing University release adds specific clinical priorities: developing safe and reliable BCI products, expanding clinical applications across brain-disorder diagnosis and treatment, motor rehabilitation, and health monitoring, and improving standards and regulatory mechanisms for BCI commercial deployment.

The state-issued language does not mention specific companies, capital allocations, or named foreign jurisdictions. The level of abstraction is consistent with how the State Council makes pillar-industry endorsements. The concrete operational consequences will surface in subsequent ministry-level directives, provincial-level funding announcements, and the implementing regulations the Nanjing University release flags.

The NJU Brain-Computer Interface Research Institute and Gulou Laboratory

Nanjing University’s Brain-Computer Interface Research Institute was unveiled at the July 2025 Brain-Computer Interface Industry Development Conference in Nanjing, alongside the Jiangsu Brain-Computer Interface Research Institute and the Nanjing Brain-Computer Interface Innovation Consortium. The institute is a recently established unit. The Nanjing University materials available do not yet make the institute’s director, faculty roster, or affiliated school structure public in English, and the prudent editorial position is not to name an unconfirmed director.

Nanjing is one of four Chinese cities now publicly anchoring a state-recognised BCI institutional vehicle, alongside Tianjin (the BCI Industrial Cluster inaugurated 29 May 2026), Shanghai (where Neuracle Technology’s Shanghai entity filed the 11 June 2026 STAR Market IPO prospectus), and Hangzhou (anchored by BrainCo’s January 2026 confidential Hong Kong Stock Exchange filing). The pattern visible is one of distributed institutional capacity across multiple major Chinese metropolitan research bases, rather than a single national centre.

How to read the signal at the political tier

The Liu Guozhong inspection is the highest-ranking on-record Chinese political statement on brain-computer interfaces in the past twelve months. Inside BCI has been tracking the China side of the four-jurisdiction posture map (Rights-First Chile, Horizontal Regulator EU, State-Patchwork US, Industrial Builder China and South Korea) through three preceding milestones: State Council Order 818, which took effect on 1 May 2026 as the parallel commercial pathway; the Tianjin BCI Industrial Cluster inauguration on 29 May 2026 with 100 million yuan in annual funding; and Neuracle’s STAR Market IPO prospectus acceptance on 11 June 2026. The Liu Guozhong inspection sits one tier above each of those milestones in the political hierarchy. Order 818 was a State Council regulation. Tianjin was a city-level inauguration with provincial framing. Neuracle was a commercial filing. A vice premier on-site inspection with on-record Xinhua statement is a formal central-government industrial signal that ranks above all three.

The Healthy China framing matters for international reading. Western analyst frames have positioned the China BCI category as a commercial-export industrial strategy on the Industrial Builder model. The Liu visit suggests that within the Chinese state, BCI is also being routed through the domestic public-health and biomedicine pillar industry channel. The two routings are not mutually exclusive. A device approved through NMPA for clinical use in China for stroke rehabilitation or epilepsy intervention, and reimbursed under the NHSA’s April 2026 guided pricing for invasive BCI procedures, becomes commercially scalable both within China and as an export commodity at the same time. The Liu visit endorses the domestic Healthy China path explicitly, which is a different and complementary signal to the Industrial Builder export framing.

What to watch

The first signal to watch is whether a National Health Commission or NMPA directive following the Liu visit references brain-computer interfaces as a specific named device category for accelerated review or pricing-pathway integration. State Council vice premier inspections are typically followed within six to twelve weeks by ministry-level implementing language. Second, whether the next round of provincial-level BCI industrial cluster announcements that follow the Tianjin template specifically reference public-health applications (stroke rehabilitation, epilepsy intervention, brain-disorder diagnosis) over industrial-export framing. Third, whether the NJU Brain-Computer Interface Research Institute’s public-facing leadership, faculty roster, and research priorities are formally published in the months following this profile-raising visit.

Liu Guozhong’s Healthy China portfolio is the structural reason this visit happened through Jiangsu Province’s BCI institution rather than through Beijing, Shanghai, or Tianjin’s industrial-policy front doors. The framing on Inside BCI’s coverage map is that the Industrial Builder bloc is now operating through two parallel channels in the same jurisdiction: industrial-policy via Tianjin and Order 818, and public-health-and-biomedicine via Nanjing University and the Liu Guozhong inspection. Both channels endorse the BCI category. They route through different ministerial portfolios and produce different downstream regulatory and reimbursement consequences.

Sources

• Chinese vice premier stresses developing biomedicine, brain-computer interface industries (Xinhua, 23 June 2026)
• Vice Premier Liu Guozhong visits the Brain-Computer Interface Research Institute at NJU (Nanjing University, 23 June 2026)
• 刘国中调研南京大学脑机接口研究院 (Nanjing University Chinese, 23 June 2026)
• State Council Vice Premiers profile (gov.cn)
• Liu Guozhong State Council profile background (Wikipedia)
• Inside BCI — Asia-Pacific synthesis piece, 21 June 2026 — Tianjin BCI Industrial Cluster, 17 June 2026 — Neuracle STAR Market IPO acceptance, 22 June 2026 — Order 818, 8 May 2026